Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6QDH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,549
Award facts
- Contract value 100% obligated
- $7,548.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,548.66 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on December 8, 2025, with a completion date of December 9, 2025. This non-compete, firm fixed-price delivery order represents a single pharmaceutical procurement from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The drug will be distributed from AmerisourceBergen's headquarters location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions, making this procurement consistent with federal healthcare supply needs for military and veteran populations.
This delivery order is issued under AmerisourceBergen's broader $999.99 billion global pharmaceutical prime vendor IDC with DLA Troop Support Medical, designated SPE2DX and valid through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains extensive contracts supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's competitive standing is reinforced by its demonstrated capability to fulfill federal procurement requirements without set-aside restrictions, positioning it as a key supplier within DLA's pharmaceutical distribution network supporting military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F6QDH?
SPE2DR26F6QDH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F6QDH worth?
The government has obligated $7,549 on SPE2DR26F6QDH.
Is contract SPE2DR26F6QDH an order under another contract?
Yes. SPE2DR26F6QDH is a delivery order under SPE2DR25D3801, an indefinite delivery contract.
Was contract SPE2DR26F6QDH competed?
The extent of competition for SPE2DR26F6QDH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award